Literature DB >> 1158087

Studies of renin and aldosterone in cirrhotic patients with ascites.

L Rosoff, P Zia, T Reynolds, R Horton.   

Abstract

Plasma renin activity and aldosterone metabolism were investigated in patients with cirrhosis and refractory ascites. All patients initially showed marked elevations of plasma and renin activity and plasma aldosterone. Although metabolic clearance of aldosterone was reduced, increased secretion rate was the major factor leading to elevated plasma levels. The elevated plasma renin activity and plasma aldosterone were only minimally affected by posture, dietary sodium restriction, and diuretic administration, suggesting a near-maximal degree of secondary aldosteronism. In most patients plasma renin activity and plasma aldosterone returned to normal when spontaneous natriuresis appeared. However, in 2 patients during spontaneous diuresis and in all 3 given aminoglutethimide, sodium excretion was poorly correlated with plasma renin activity and plasma aldosterone, suggesting that other tubular and/or vascular factors are important in the intense sodium reabsorption found with cirrhosis and ascites.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1158087

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Renal sodium retention in liver disease.

Authors: 
Journal:  West J Med       Date:  1983-06

2.  Management of hepatic ascites.

Authors: 
Journal:  Br Med J       Date:  1978-01-14

3.  Renal hemodynamics and the renin--angiotensin system in cirrhosis: relationship to sodium retention.

Authors:  L Rosoff; J Williams; P Moult; H Williams; S Sherlock
Journal:  Dig Dis Sci       Date:  1979-01       Impact factor: 3.199

4.  Renal function impairment induced by change in posture in patients with cirrhosis and ascites.

Authors:  M Bernardi; C Santini; F Trevisani; M Baraldini; A Ligabue; G Gasbarrini
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

5.  [Kidney involvement in liver diseases. Pathophysiology and clinical course].

Authors:  P Schmidt
Journal:  Klin Wochenschr       Date:  1983-10-17

6.  Clinical significance of plasma endothelin-1 in patients with chronic liver disease.

Authors:  H Matsumoto; J Uemasu; M Kitano; H Kawasaki
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

7.  Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver.

Authors:  H Wernze; H J Spech; G Müller
Journal:  Klin Wochenschr       Date:  1978-04-15

8.  Factors that determine refractoriness of ascites to conventional therapy.

Authors:  S Amra; R Elie; I Kronborg
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

9.  Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.

Authors:  M Bernardi; F Trevisani; C Santini; R De Palma; G Gasbarrini
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

10.  Physiologic and pharmacologic effects of glucocorticoids on ion transport across rabbit ileal mucosa in vitro.

Authors:  J H Sellin; M Field
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.